Literature DB >> 2054143

Effect of L-dopa, oxyferriscorbone and ferrous iron on in vivo lipid peroxidation.

P Dostert1, M S Benedetti, E Frigerio.   

Abstract

We report here on an in vivo model of lipid peroxidation, which consists in measuring the amount of ethane present in the exhaled air after the oral administration of linolenic acid to rats. This model was used to study the effect of L-dopa, oxyferriscorbone (OFS), a ferri-ferro-complex, and ferrous iron, this latter alone or associated with ascorbic acid, on lipid peroxidation. Intravenous or oral administration of L-dopa did not influence the amount of ethane produced by an oral dose of 1.25 ml/kg of linolenic acid. Intravenous injection of OFS (50 mg/kg) as well as the co-injection of FeSO4, 7H2O (15 mg/kg) and ascorbic acid (15 mg/kg) were found to decrease the amount of ethane produced by 1.25 ml/kg of linolenic acid given orally, whereas the same dose of ferrous sulfate alone was ineffective. The possible causes which might underlie the absence of effects of L-dopa and ferrous iron and the partial inhibition of lipid peroxidation by OFS and ferrous ions associated with ascorbic acid are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2054143     DOI: 10.1007/bf01249115

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  25 in total

1.  Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains.

Authors:  P Riederer; E Sofic; W D Rausch; B Schmidt; G P Reynolds; K Jellinger; M B Youdim
Journal:  J Neurochem       Date:  1989-02       Impact factor: 5.372

2.  Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease.

Authors:  D T Dexter; C J Carter; F R Wells; F Javoy-Agid; Y Agid; A Lees; P Jenner; C D Marsden
Journal:  J Neurochem       Date:  1989-02       Impact factor: 5.372

3.  Lipid peroxidation as cause of nigral cell death in Parkinson's disease.

Authors:  D Dexter; C Carter; F Agid; Y Agid; A J Lees; P Jenner; C D Marsden
Journal:  Lancet       Date:  1986-09-13       Impact factor: 79.321

4.  Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease.

Authors:  D T Dexter; F R Wells; A J Lees; F Agid; Y Agid; P Jenner; C D Marsden
Journal:  J Neurochem       Date:  1989-06       Impact factor: 5.372

5.  Ethane evolution: a new index of lipid peroxidation.

Authors:  C A Riely; G Cohen; M Lieberman
Journal:  Science       Date:  1974-01-18       Impact factor: 47.728

6.  Ethane exhalation as an index of in vivo lipid peroxidation: concentrating ethane from a breath collection chamber.

Authors:  G D Lawrence; G Cohen
Journal:  Anal Biochem       Date:  1982-05-15       Impact factor: 3.365

7.  Iron, a new aid in the treatment of Parkinson patients.

Authors:  W Birkmayer; J G Birkmayer
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

8.  Ethene (ethylene) and ethane exhalation in Ni[II]-treated rats, using an improved rebreathing apparatus.

Authors:  J A Knight; S M Hopfer; M C Reid; S H Wong; F W Sunderman
Journal:  Ann Clin Lab Sci       Date:  1986 Sep-Oct       Impact factor: 1.256

9.  Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.

Authors:  E Sofic; P Riederer; H Heinsen; H Beckmann; G P Reynolds; G Hebenstreit; M B Youdim
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

10.  A new potent inhibitor of lipid peroxidation in vitro and in vivo, the hepatoprotective drug anisyldithiolthione.

Authors:  D Mansuy; A Sassi; P M Dansette; M Plat
Journal:  Biochem Biophys Res Commun       Date:  1986-03-28       Impact factor: 3.575

View more
  1 in total

1.  Oxidant/antioxidant status in obese adolescent females with acne vulgaris.

Authors:  Khalid O Abulnaja
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.